high dose ipamorelin CJC-1295 + CJC-1295 Without DAC / Ipamorelin
Description
BPC-157 may help connective tissues heal much faster, while also improving digestive health and treating ulcer damage
Lopes et al., 2019)
Recently, integrated multi-omics data show decrease in CXCL10 is a promising drug target, since it accounts for about 70% of the effects mediated by pharmacological IL-6R inhibition in a clinical trial (100)
The limitation is non-specific targeting of visceral fat, which is where Tesamorelin complements the protocol
